Zacks Research Has Pessimistic Outlook of MOH Q2 Earnings

Molina Healthcare, Inc (NYSE:MOH) – Investment analysts at Zacks Research cut their Q2 2025 earnings per share estimates for shares of Molina Healthcare in a report issued on Monday, July 14th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $5.51 per share for the quarter, down from their prior estimate of $6.11. The consensus estimate for Molina Healthcare’s current full-year earnings is $24.40 per share. Zacks Research also issued estimates for Molina Healthcare’s Q3 2025 earnings at $5.72 EPS, Q4 2025 earnings at $5.04 EPS, FY2025 earnings at $22.35 EPS, Q3 2026 earnings at $5.28 EPS, Q4 2026 earnings at $6.98 EPS, FY2026 earnings at $25.24 EPS, Q1 2027 earnings at $9.24 EPS, Q2 2027 earnings at $7.59 EPS and FY2027 earnings at $28.63 EPS.

Several other research analysts have also weighed in on MOH. Mizuho set a $330.00 target price on shares of Molina Healthcare and gave the stock an “outperform” rating in a research report on Friday, July 11th. Wall Street Zen lowered shares of Molina Healthcare from a “buy” rating to a “hold” rating in a research report on Sunday, June 29th. Truist Financial lowered their target price on shares of Molina Healthcare from $400.00 to $335.00 and set a “buy” rating on the stock in a research report on Wednesday. Robert W. Baird restated a “neutral” rating and set a $375.00 target price (up from $331.00) on shares of Molina Healthcare in a research report on Tuesday, April 15th. Finally, Barclays lowered their target price on shares of Molina Healthcare from $351.00 to $347.00 and set an “equal weight” rating on the stock in a research report on Monday, June 9th. Eleven research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $347.57.

Molina Healthcare Trading Down 10.7%

Shares of MOH opened at $182.47 on Thursday. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.87. The firm’s 50-day moving average is $281.73 and its two-hundred day moving average is $300.30. Molina Healthcare has a twelve month low of $182.09 and a twelve month high of $365.23. The firm has a market capitalization of $9.89 billion, a P/E ratio of 8.81, a PEG ratio of 0.91 and a beta of 0.55.

Molina Healthcare (NYSE:MOH) last issued its earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share for the quarter, topping the consensus estimate of $5.96 by $0.12. Molina Healthcare had a net margin of 2.81% and a return on equity of 28.38%. The company had revenue of $11.15 billion for the quarter, compared to analyst estimates of $10.86 billion. During the same period in the prior year, the business posted $5.73 earnings per share. The firm’s revenue for the quarter was up 12.2% compared to the same quarter last year.

Insider Activity at Molina Healthcare

In other news, Director Richard M. Schapiro sold 669 shares of the stock in a transaction that occurred on Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total value of $214,414.50. Following the sale, the director directly owned 11,244 shares in the company, valued at $3,603,702. This represents a 5.62% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Joseph M. Zubretsky sold 87,500 shares of the firm’s stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the sale, the chief executive officer owned 257,715 shares in the company, valued at approximately $82,484,262.90. This trade represents a 25.35% decrease in their position. The disclosure for this sale can be found here. 1.10% of the stock is owned by corporate insiders.

Institutional Trading of Molina Healthcare

A number of hedge funds have recently bought and sold shares of MOH. Raymond James Financial Inc. acquired a new stake in Molina Healthcare during the fourth quarter worth approximately $10,725,000. Sequoia Financial Advisors LLC boosted its position in Molina Healthcare by 28.2% during the fourth quarter. Sequoia Financial Advisors LLC now owns 1,532 shares of the company’s stock worth $446,000 after acquiring an additional 337 shares during the last quarter. EverSource Wealth Advisors LLC boosted its position in Molina Healthcare by 81.5% during the fourth quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company’s stock worth $57,000 after acquiring an additional 88 shares during the last quarter. Avantax Advisory Services Inc. boosted its position in Molina Healthcare by 7.6% during the fourth quarter. Avantax Advisory Services Inc. now owns 1,416 shares of the company’s stock worth $412,000 after acquiring an additional 100 shares during the last quarter. Finally, Natixis Advisors LLC boosted its position in Molina Healthcare by 6.7% during the fourth quarter. Natixis Advisors LLC now owns 29,928 shares of the company’s stock worth $8,711,000 after acquiring an additional 1,881 shares during the last quarter. Institutional investors and hedge funds own 98.50% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.